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ABSTRACT
Uch37 is a de-ubiquitinating enzyme that is activated by
Rpn13 and involved in the proteasomal degradation of
proteins. The full-length Uch37 was shown to exhibit low
iso-peptidase activity and is thought to be auto-inhibited.
Structural comparisons revealed that within a homo-
dimer of Uch37, each of the catalytic domains was
blocking the other’s ubiquitin (Ub)-binding site. This
blockage likely prevented Ub from entering the active site
of Uch37 and might form the basis of auto-inhibition. To
understand the mode of auto-inhibition clearly and shed
light on the activationmechanism of Uch37 by Rpn13, we
investigated the Uch37-Rpn13 complex using a combi-
nation of mutagenesis, biochemical, NMR, and small-
angle X-ray scattering (SAXS) techniques. Our results
also proved that Uch37 oligomerized in solution and had
very low activity against the ﬂuorogenic substrate ubi-
quitin-7-amino-4-methylcoumarin (Ub-AMC) of de-ubiq-
uitinating enzymes. Uch37ΔHb,Hc,KEKE, a truncation
removalof theC-terminal extension region (residues256–
329) converted oligomeric Uch37 into a monomeric form
that exhibited iso-peptidase activity comparable to that of
a truncation-containing the Uch37 catalytic domain only.
Wealso demonstrated that Rpn13C (Rpn13 residues 270–
407) could disrupt the oligomerization of Uch37 by
sequestering Uch37 and forming a Uch37-Rpn13 com-
plex. Uch37 was activated in such a complex, exhibiting
12-fold-higher activity than Uch37 alone. Time-resolved
SAXS (TR-SAXS) and FRET experiments supported the
proposed mode of auto-inhibition and the activation
mechanism of Uch37 by Rpn13. Rpn13 activated Uch37
by forming a 1:1 stoichiometric complex in which the
active site of Uch37 was accessible to Ub.
KEYWORDS Uch37-Rpn13 complex, de-ubiquitination,
SAXS analysis, oligomerization, iso-peptidase
INTRODUCTION
The 26S proteosome is a large, modular, multi-protein
complex composed of the 20S catalytic core particle (CP)
and the 19S regulatory particle (RP). The barrel-shaped 20S
CP is associated with the 19S RP in a 1:2 stoichiometry.
Prior to degradation, the target protein is ﬁrst de-
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ubiquitinated. The RP module is responsible for the recog-
nition of the ubiquitin (Ub) chain and for its subsequent de-
ubiquitination. The 19S RP can recognize Ub using at least
two Ub receptors—Rpn10 and Rpn13. Rpn10 (also called
PMSD5 and S5A) contains two Ub-interacting motifs (UIMs),
which display selectivity for longer poly-Ub chains (Young
et al., 1998; Glickman et al., 2009). In contrast, Rpn13 (also
called ADRM1) is a recently identiﬁed Ub receptor com-
prising 407 amino acids (AAs), with an N-terminal pleckstrin-
like receptor for the Ub (Pru) domain (AA 22–130; also
known as the ubiquitin-binding domain, or UBD) that can
bind K48-linked di-Ub (Groll et al., 2008; Husnjak et al.,
2008) and a C-terminal domain (AA 253–407; i.e., Uch37-
binding domain) (Fig. 1A). Once there is recognition, the
process of de-ubiquitination is initiated by de-ubiquitinating
enzymes (DUBs), such as Rpn11 (also called POH1 and
PMSD14), Usp14, and Uch37 (Reyes-Turcu et al., 2009).
Together, these DUBs disassemble the poly-Ub chain and
recycle the ubiquitin during proteasomal degradation. After
de-ubiquitination, the protein is partially unfolded and trans-
located into the cavity of the 20S CP for degradation via a
threonine-dependent nucleophilic attack (Voges et al., 1999;
Zhu et al., 2005; Liu et al., 2006).
Ubiquitin C-terminal hydrolases (UCHs) release active Ub
from Ub adducts or precursors and have been shown to play
important roles in cellular events, such as DNA repair, pro-
tein degradation, and modulation of signaling pathways. At
least four different types of UCHs are known to exist in
human beings-UCH-L1, UCH-L3, UCH-L5, and BAP1.
These enzymes have a highly conserved catalytic core
(UCH) domain consisting of approximately 220 residues.
The crystal structures of the UCH domain for UCH-L1, UCH-
L3, and YUH1 (UCH homolog in yeast) are known (Johnston
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Figure 1. Oligomerization of Uch37 in solution. (A) Diagrammatic representation of the constructs of Uch37 and Rpn13 used in
this study. (B) Cartoon representation of the structure of Rpn13C solved by NMR. The color representation of Rpn13 is shown as the
same as Fig. 1A. (C) Overlay of the cartoon of the NMR structure of Rpn13C (AA 270–407) over the NMR structure of the full-length
Rpn13 (grey color; PDB ID 2KR0). The truncation had no effect on the folding of the protein. (D) Size exclusion proﬁles revealed that
Uch37 has a shorter retention time than the Uch37-Rpn13C complex. Proteins from the peaks were analyzed by SDS-PAGE (inset).
Ovalbumin (44 kDa) and γ-globulin (158 kDa) were run as standards under identical conditions. The positions of the standards are
marked with green arrows. (E) Analytical ultracentrifugation (AUC) analysis of Uch37 and the Uch37-Rpn13C complex. Uch37 was
heterogeneous and exhibited two distinct peaks, whereas the Uch37-Rpn13C complex was homogenous. The sedimentation co-
efﬁcient (S value) calculated for Uch37 and the Uch37-Rpn13C complex are shown in the inset.
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et al., 2006). Recently, structures of the UCH catalytic
domain and the full-length Uch37 were also reported (Nishio
et al., 2009; Burgie et al., 2011; Maiti et al., 2011). The
topology and overall conﬁguration of the UCH domain are
similar in all hydrolases. In addition, all UCHs appear to
contain a ﬂexible active site cross-over polypeptide loop that
regulates entry of the substrate into the active site and to
impart its speciﬁcity (Popp et al., 2009; Zhou et al., 2012).
Human ubiquitin C-terminal hydrolase Uch37 (also called
ubiquitin carboxy-terminal hydrolase isozyme L5, UCH-L5) is
a 37 kDa de-ubiquitinating enzyme composed of an N-ter-
minal UCH domain and C-terminal extension region
(Fig. 1A). Uch37 progressively removes Ub from the distal
part of the poly-Ub chain, which may rescue poorly ubiqui-
tinated proteins from proteolysis (Lam et al., 1997; Koulich
et al., 2008). The C-terminal extension region of Uch37 plays
an important role in several protein-protein interactions. For
example, Smad7 acts as an adaptor molecule to recruit
Uch37 to the type I TGF-β (transforming growth factor-β)
receptor, where Uch37 up-regulates TGF-β-dependent gene
expression by de-ubiquitinating and stabilizing the type I
TGF-β receptor (Wicks et al., 2005; Ventii and Wilkinson,
2008). The Ino80 complex, an ATP-dependent chromatin
remodeling complex, associates with and recruits Uch37 to
the nucleosome during transcription and DNA repair by
NFRKB (Yao et al., 2008). Another important protein-protein
interaction of Uch37 that has been studied extensively is its
association with Rpn13. The full-length Uch37 exhibits low
iso-peptidase activity against Ub-AMC (ubiquitin-7-amino-4-
methylcoumarin) (Yao et al., 2006). Rpn13 can interact with
Uch37 and recruit it to the proteasome via its C-terminal 46
residues (also called the KEKE motif) and activates Uch37.
The de-ubiquitination activities of this activated Uch37 have
been shown to be higher than those of the UCH catalytic
domain alone (Hamazaki et al., 2006; Qiu et al., 2006; Yao
et al., 2006). Interestingly, a truncation of Uch37 containing
the UCH core domain alone exhibited activity comparable to
that of its homolog UCH-L3 (Yin et al., 2011), suggesting that
the C-terminal extension region likely plays an important role
in the auto-inhibition of Uch37. Furthermore, whereas the
Rpn13-Uch37 complex can hydrolyze only small adducts of
ubiquitin, such as Ub-AMC, a Rpn13-Uch37 complex that is
incorporated on 19S RP can process large ubiquitin conju-
gates, such as di-ubiquitin (Yao et al., 2006).
The C-terminus of Uch37 might contain clues that explain
how the full-length Uch37 remains auto-inhibited whereas
the isolated UCH domain of the same protein exhibits
activity. As discussed by Burgie et al., the Uch37 tetramer
observed in the crystal structure could impose auto-inhibition
in which the oligomeric assembly of Uch37 sterically pre-
cludes ubiquitin binding (Burgie et al., 2011). The C-terminus
of Rpn13 has been shown to speciﬁcally bind to and activate
Uch37 (Hamazaki et al., 2006; Qiu et al., 2006; Yao et al.,
2006). However, the mechanism by which Rpn13 activates
Uch37 is not known. To gain a clear understanding of the
auto-inhibition mechanism of Uch37 and the Uch37 activa-
tion by Rpn13, we investigated the Uch37-Rpn13 complex
using a combination of mutagenesis, biochemical, NMR, and
SAXS analyses. Initially, a role for the C-terminal region of
Uch37 in the oligomerization of the protein was established
by characterizing the relationship between the oligomeriza-
tion states of several C-terminal truncations of Uch37 and
their activities. These results were compared with the olig-
omerization state and stoichiometry of the Uch37-Rpn13
complex in solution to determine whether a change in the
oligomerization state of the protein results in the activation of
Uch37. These data coupled with the SAXS analysis of
Uch37 alone and its complex with Rpn13 in solution pro-
vided the structural basis for the auto-inhibition of Uch37 in
solution. A mechanism for the activation of Uch37 by Rpn13
is discussed.
RESULTS AND DISCUSSION
NMR structure of the Rpn13 C-terminal domain
Our initial attempts at crystallizing the full-length Rpn13
failed. Analysis of Rpn13 using secondary structure predic-
tion programs suggested the presence of an approximately
130-AA-long loop connecting the Pru domain to the C-ter-
minal domain. This prediction was later conﬁrmed by NMR
models of the full-length Rpn13 (Chen et al., 2010). Fur-
thermore, it is known that the Rpn13 C-terminal domain can
interact with Uch37 via its KEKE motif and activate Uch37 in
a manner similar to that of the full-length Rpn13. Using this
information, we designed seven Rpn13 C-terminal con-
structs with domain boundaries encompassing residues
211–407, 230–407, 253–407, 259–407, 270–407, 283–407,
and 297–407. One of these constructs, AA 270–407 (here-
after referred to as Rpn13C) (Fig. 1A), was sufﬁciently stable
when kept at 25°C. Therefore, we used this Rpn13C for
further analysis of the Rpn13-Uch37 complex.
To determine whether the truncation had any effect on the
overall structure of Rpn13, we solved the structure of
Rpn13C using NMR independently (Fig. 1B) and compared it
to the structures of the full-length Rpn13 (PDB ID 2KR0) and
the AA 253–407 fragment (PDB ID 2KQZ) solved by Chen
et al. (Chen et al., 2010). The statistics of the ﬁnal model are
listed in Supplementary Table S1. The NMR structure of
Rpn13C was similar to that of the same region in the full-
length protein (PDB ID 2KR0; Fig. 1B and 1C), except for
some minor deviations of a few N-terminal residues.
Because this truncation did not appear to distort the overall
structure of the protein, Rpn13C was used for the sub-
sequent studies.
Oligomerization state analysis of Uch37 alone and its
complex with Rpn13
Preliminary size exclusion chromatography (SEC) studies of
Uch37 and its complex with Rpn13C revealed that at a
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concentration of approximately 10 mg/mL, Uch37 had a
smaller retention volume than the Uch37-Rpn13C complex
(Fig. 1D). This ﬁnding was unexpected and provided the ﬁrst
indication that the oligomerization of Uch37 might be differ-
ent between Uch37 alone and the Uch37-Rpn13C complex.
To determine the oligomerization state of Uch37 under
solution conditions, we injected different concentrations of
Uch37 into a 120-mL Superdex G200 SEC column and
estimated the MWs of the proteins from their elution volumes
using a standard curve. The MWs observed for Uch37 at 0.4,
1.6, and 10 mg/mL were 50.7, 58, and 128.9 kDa, respec-
tively (Table 1 and Fig. S1). These results indicated a con-
centration-dependent oligomerization of Uch37, which is
consistent with the previous report by Burgie et al. (Burgie
et al., 2011). In sharp contrast, the elution volume of the
Uch37-Rpn13C complex was independent of the concen-
tration. The complex eluted at 77.92 and 77.84 mL at con-
centrations of 1.2 and 8 mg/mL, respectively. The MWs for
these elution volumes were 66.4 and 66.8 kDa, respectively
(Table 1). The exact oligomerization state of Uch37-Rpn13C
complex could not be determined from the SEC proﬁle
because the theoretical MW of the complex calculated from
its primary amino acid sequence is approximately 52.6 kDa.
The SDS-PAGE analysis of the protein from the peak indi-
cated the presence of both Uch37 and Rpn13C. Therefore,
Uch37 and Rpn13C likely formed a stable complex. We
performed analytical ultracentrifugation (AUC) analysis to
further conﬁrm the MW and to obtain the oligomerization
state of the Uch37-Rpn13C complex. Sedimentation velocity
experiments revealed a single, sharp peak with an S value of
3.20 corresponding to a MW of approximately 56.4 kDa
(Fig. 1E). This MW, which is close to the theoretical MW
(52.6 kDa) of the Uch37-Rpn13C complex, suggested that
the Uch37-Rpn13C complex existed as a heterodimer in
solution. A frictional ratio of 1.577 (f/f0 > 1.2) indicated that
the Uch37-Rpn13C complex adopted an elongated shape in
solution (Supplementary Table S2).
Figure 2 presents the SAXS data collected for different
concentrations of Uch37 and the Uch37-Rpn13C complex,
and Table 2 lists the parameters derived from those curves.
The Guinier plots clearly indicated that no discernible
aggregation or radiation damage occurred during the data
collection (Figs. 2A and 1B). The P(r) curve of Uch37 con-
tained a major peak at 38 Å and a small shoulder at 58 Å,
with a Dmax of 125 Å, indicating that Uch37 assumed an
elongated conformation in solution. Alternatively, Uch37
could be more compact when associated with Rpn13C
(Fig. 2C). The Kratky plots of both Uch37 and the Uch37-
Rpn13C complex exhibited a clear peak with plateaus
(Fig. 2D). This ﬁnding suggested that both Uch37 and the
Uch37-Rpn13C complex were well folded and contained
some ﬂexible regions. The MWs calculated from the SAXS P
(r) functions for Uch37 and Uch37-Rpn13C complex were
approximately 117.7 and 64.6 kDa, respectively. When
compared to the theoretical MWs (Uch37, 37 kDa; Uch37-
Rpn13C complex, 52.6 kDa), the SAXS-based MW estima-
tions further highlighted the ability of Uch37 to form oligo-
mers, although the Uch37-Rpn13C complex might exist as a
heterodimer.
Taken together, the SEC, AUC, and SAXS analyses of
different concentrations of Uch37 suggested that Uch37
could exist as a mixture of different oligomeric states in
solution and Uch37 was de-oligomerized in the presence of
Rpn13, forming a stable heterodimer of Rpn13 and Uch37.
Table 1. Molecular weights and oligomerization states of Uch37 and its complex with Rpn13C estimated by different methods
Protein MW (kDa) calculated
from primary sequence





Uch37 37.0 SEC 0.4 50.7 Monomer, dimer
1.6 58.0 Monomer, dimer
10.0 128.9 Trimer, tetramer
AUC ∼1.0 28.8 and 50.1 Monomer, dimer
SAXS 1.3 117.7 Dimer, trimer, tetramer
Uch37-Rpn13C 52.5 SEC 1.2 66.4 Monomer
8.0 66.8 Monomer
AUC ∼1.0 56.4 Monomer
SAXS 1.3 64.6 Monomer
Uch37ΔHb,Hc,KEKE 29.1 SEC >7.0 34.3 Monomer
Uch37ΔHc,KEKE 33.3 SEC >4.0 38.0 Monomer
AUC ∼1.0 30.1 Monomer
Uch37ΔKEKE 34.9 SEC >1.5 41.9 Monomer
SEC, size exclusion chromatography; AUC, analytical ultracentrifugation; SAXS, small angle X-ray scattering.
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However, the factors that trigger the oligomerization of
Uch37 inside the cell are currently unclear. In addition,
Burgie et al. discussed the factors that could cause molec-
ular crowding of Uch37 and its subsequent oligomerization
(Burgie et al., 2011).
Oligomerization of Uch37 and its de-oligomerization
by Rpn13
We used a known crystal structure of Uch37 (PDB ID 3IHR)
(Burgie et al., 2011) to gain information about the mode of
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Figure 2. SAXS analysis of Uch37 and Uch37-Rpn13C. The scattering curves for Uch37 (A) and the Uch37-Rpn13C complex
(B) generated from different concentrations of the protein were similar. The P(r) distribution function (C) and Kratky plots (D) of Uch37
and the Uch37-Rpn13C complex were calculated from the experimental data. The plots suggested that there was neither any
concentration-dependent aggregation nor any radiation damage during the SAXS data collection.
Table 2. Parameters derived from SAXS curves
Protein sample Rg (Å)
a Dmax (Å)
b VPorod (Å
3)c MWd (kDa) Oligomeric state
Uch37 40.74 ± 0.14 120–130 197,367 ± 12,025 117.7 ± 1.1 Dimer and tetramer
Uch37-Rpn13C 29.73 ± 0.17 85–90 90,879 ± 1403 64.6 ± 1.0 Heterodimer
a The real-space Rg was estimated by calculating P(r) using GNOM.
b Dmax was estimated by calculating P(r) using GNOM.
c The Porod volume was calculated using PRIMUS.
d The molecular weights (MWs) were predicted using the web server http://www.if.sc.usp.br/∼saxs/saxsmow.html) (Fischer et al., 2010).
e Values are the average of three independent experiments; error bars represent the standard error of the mean.
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oligomerization of Uch37 using PDBePISA (http://www.ebi.
ac.uk/msd-srv/prot_int/) (Krissinel and Henrick, 2007), a
program that determines the oligomerization state of a pro-
tein from its crystal structure. Inspection of the symmetry
mates revealed that two Uch37 molecules formed extensive
hydrogen bonds and salt bridges at the N-terminal core
domain, and the major contact area spanned 1,831.2 Å2 and
was 11.1% of the surface area of each monomer. The sol-
vation free energy gained upon formation of the interface
(ΔiG) was calculated to be 6.8 kcal/mol. Two such dimers
then assembled into a tetramer through interactions involv-
ing the C-terminal extension region (Fig. S2A and S2B). The
solvent-accessible surface area of monomeric units buried
upon formation of the tetrameric assembly was 12,600 Å2.
This analysis suggests that Uch37 most likely forms and
exists as a dimer or tetramer in solution. Interestingly, this
type of analysis using the structure of the Uch37 catalytic
domain (PDB ID 3A7S) indicated that it could not form a
dimer or tetramer. However, the possibility that Uch37 forms
other oligomeric states when other factors are present in the
solution cannot be ruled out.
We also performed time-resolved small-angle X-ray
scattering (TR-SAXS) experiments to monitor the de-oligo-
merization of (Uch37)n (where n is the number of Uch37
molecules in the oligomer) during its transition from an oli-
gomer to a monomer in the presence of Rpn13C. The
change in the values of I0 and Rg as a function of time
(Fig. 3A and 3B) supports the following proposed mecha-
nism for de-oligomerization of Uch37 by Rpn13C:
I. (Uch37)n + Rpn13C→ (Uch37)n/Rpn13C, where n can be
2–4 and (Uch37)n/Rpn13C is an intermediate complex;
II. (Uch37)n/Rpn13C→Uch37-Rpn13C+ (Uch37)n-1, where
Uch37-Rpn13C is the complex of Uch37 and Rpn13C;
III. Uch37 + Rpn13C → Uch37-Rpn13C.
In this mechanism, steps I and II appear to occur con-
currently until all Uch37 oligomers are consumed, whereas
step III is a relatively slower step. An explanation for this
mechanism can be formed based on the following obser-
vation. After the mixing of Uch37 with Rpn13C, the I0 of the
system increased initially (<20 ms post mixing) compared to
the I0 of a simple mixing case in which the samples were
assumed to be physically mixed without any chemical
reaction (Fig. 3A). A moderate increase in the I0 implied that
Rpn13C interacted with the oligomerized Uch37 [(Uch37)n],
forming a larger intermediate (Uch37)n/Rpn13C complex.
During the same time interval (<20 ms), the Rg value of the
system did not change signiﬁcantly because the Rg values of
(Uch37)n and (Uch37)n/Rpn13C are similar (Fig. 3B). The
decrease in the apparent Rg and I0 in the range from 20 ms
to 1 s mainly resulted from the repetitive processes of step II.
That decrease followed by a slight increase in Rg and I0
during the 1–100 s range could have arisen from a situation
in which (Uch37)n and (Uch37)n/Rpn13C were most likely all
consumed, and step III became the major reaction process
(Fig. 3A and 3B). Thus, the changes in Rg and I0 support the
hypothesis that Rpn13C could disrupt the Uch37 oligomeri-
zation and form a heterodimer.
To further conﬁrm the oligomerization of Uch37 in solution,
assays based on ﬂuorescence resonance energy transfer
(FRET) were used to monitor both the oligomers of Uch37 in
solution and their de-oligomerization by Rpn13C. Hetero-olig-
omersofUch37 thatwere randomly labeledwithAlexaFluor647
and Alexa Fluor 555 were formed as described in the Methods.
FRETwill occur when Alexa Fluor 647 and Alexa Fluor 555 are
sufﬁciently close (<80 Å); the model, which is most likely to be
tetrameric (Fig. S3), indicates that this distance requirement is
met for Uch37 oligomers. As expected, we detected signiﬁcant
FRET for Uch37 (labeled with Alexa Fluor 647 or Alexa Fluor
555) alone at a concentration of 250nmol/L (approximately 9.25
μg/mL) (Fig. 3C). The addition of Rpn13C, which monomerizes
the Uch37, resulted in a decrease in FRET, as indicated by the
decrease in the acceptor ﬂuorescence at 664 nm and the cor-
responding increase in the donor ﬂuorescence at 553 nm
(Fig. 3C). Thus, the FRET assay further conﬁrmed that the
oligomerization of Uch37 and its de-oligomerization byRpn13C
even at extremely low concentrations.
To conﬁrm that the interaction of Rpn13C with Uch37 was
speciﬁc, we performed surface plasmon resonance (SPR)
experiments and measured the afﬁnity between Rpn13C and
Uch37. Uch37 bound to Rpn13C tightly with a low dissociation
constant (Kd = 5.35 nmol/L, Fig. 3D). Interestingly, 4mol/LNaCl
could not reverse the interaction between Uch37 and Rpn13C,
indicating a role for hydrophobic interactions in the formation of
the complex (Fig. 3E). Rpn13C could be dissociated from
Uch37 in the presence of 15 mmol/L NaOH (Fig. 3E).
Deletion of the C-terminal region de-oligomerized
Uch37
The C-terminal extension region of Uch37 folds into three α-
helices—helix a (Ha), residues 226–245; helix b (Hb), resi-
dues 256–288; and helix c (Hc), residues 291–303—followed
by a long ﬂexible region spanning residues 304–329 and
containing the KEKEmotif (Fig. 4A). All three helices have the
potential to form a coiled-coil motif, which has been implicated
in protein-protein interactions, particularly in the formation of
multimeric complexesandmolecular recognition (Zhanget al.,
2009; Larzabal et al., 2010). SCORER 2.0 software identiﬁed
that Hc formed perfect coiled-coil motifs (Armstrong et al.,
2011). As predicted, four Hc helices interacted with each other
mainly through hydrophobic residues, such as F294, I295,
L298, and T301, as shown in Supplementary Fig. S2C.
To investigate the biological role of Hb, Hc, and the KEKE
motif, threeC-terminal truncationsofUch37,Uch37ΔHb,Hc,KEKE,
Uch37ΔHc,KEKE, andUch37ΔKEKE,were constructed (Fig. 1A).
The oligomerization states of all three truncations were
analyzed by SEC and AUC. The theoretical MWs calculated
Mechanism of the Rpn13-induced activation RESEARCH ARTICLE


























































































































Figure 3. TR-SAXS, FRET, and SPR analysis of the Uch37-Rpn13C complex. (A) Graph of scattering intensity (I0) versus time
and radius of gyration (Rg) versus time (B) during time-resolved SAXS analysis of a mixture of Uch37 and Rpn13C. Simple mixing
represents the scenario where samples are assumed to be physically mixed without any chemical reaction taking place between the
samples. The I0 and Rg values of Uch37 alone, Rpn13C alone, and the Uch37-Rpn13C complex are shown as red dots. The error
bars represent the standard error of the mean of three independent measurements. (C) For the FRET experiments, three out of four
cysteines present in Uch37 were mutated to alanine. Cys27 of Uch37 was conjugated to Alexa Fluor 555 (absorption maxima at 555
nm; emission maxima at 565 nm) and Alexa Fluor 647 (absorption maxima at 650 nm; emission maxima at 668 nm) (referred to as
C27-label) randomly according to the manufacturer’s instructions. For all emission scans, the ﬂuorophores in solution were excited at
550 nm, and their ﬂuorescence emission was measured from 525 to 750 nm. The FRET experiment illustrating the decrease in the
acceptor ﬂuorescence at 664 nm and the corresponding increase in the donor ﬂuorescence at 553 nm upon the addition of Rpn13C
suggests reversal of the Uch37 oligomerization. (D, E) SPR analysis of the binding of Uch37 to Rpn13C. Rpn13C was immobilized,
whereas a gradient of Uch37 was applied to quantify the binding afﬁnity (panel D). Different colors indicate different concentrations of
Uch37: green (15.6 nmol/L), yellow (31.2 nmol/L), blue (62.5 nmol/L), pink (125 nmol/L), cyan (250 nmol/L), and red (500 nmol/L). The
binding was strong, and neither BSA (10 mg/mL) nor NaCl (4 mol/L) could break the complex. The proteins could be separated using
15 mmol/L NaOH (panel E).
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high to be measured
Figure 4. Deletion of the C-terminal region de-oligomerized and activated Uch37. (A) Cartoon of Uch37 depicting regions of the
C-terminal extension region (helices a, b, and c and the KEKE motif). (B) Size exclusion proﬁles of the Uch37 truncations. The
truncations of the C-terminal extension region had longer retention times than the full-length Uch37. Ovalbumin (44 kDa) and γ-
globulin (158 kDa) were run as standards under identical conditions. The positions of the standards are marked with green arrows.
(C–E) The activity of Uch37 in the presence or absence of the full-length Rpn13 or N-terminal truncated (Δ1−269) Rpn13C was
measured using Ub-AMC as the substrate. The relative ﬂuorescence units emitted by different constructs are shown as a function of
time (C). Uch37 exhibited the highest activity in the presence of Rpn13. UCH-L3 was used as a control, with its activity considered to
be 100 %. Uch37N, Δbc, Δc, and ΔKEKE represent the Uch37 catalytic domain, Uch37Δb,c,KEKE, Uch37Δc,KEKE, and Uch37ΔKEKE,
respectively (D). (E) Uch37 at different concentrations could be activated by Rpn13C. The values are the average of three
independent experiments; the error bars represent the standard error of the mean.
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from the sequences were 29.1, 33.3, and 34.9 kDa for
Uch37ΔHb,Hc,KEKE, Uch37ΔHc, KEKE, and Uch37ΔKEKE,
respectively. Interestingly, at approximately 10mg/mL, all three
truncations eluted as single peaks in SEC using a 120 mL
Superdex G200 column. The retention volumes were 86.46,
84.76, and 83.89 mL for Uch37ΔHb,Hc,KEKE, Uch37ΔHc,KEKE,
and Uch37ΔKEKE, respectively (Fig. 4B). From the standard
curve, theestimatedMWsforUch37ΔHb,Hc,KEKE,Uch37ΔHc,KEKE
and Uch37ΔKEKE were 34.6, 39.4, and 43.7 kDa, respectively,
suggesting that all three truncations existed as monomers.
However, the full-length Uch37 had a shorter retention time
(69.21mL) and eluted as an oligomer (estimatedMWof 128.9
kDa) when subjected to SEC under identical conditions
(Fig. 4B). Next, we performedAUCanalysis onUch37ΔHc,KEKE
andUch37ΔKEKE to furtherconﬁrm theoligomerizationstatesof
the proteins. The root-mean-square deviation (r.m.s.d.) of the
best ﬁtting to the continuous sizedistributionmodel was 0.0072
for Uch37Δc,KEKE and 0.0070 for Uch37ΔKEKE (Table S2).
Sedimentation velocity experiments revealed that the
Uch37ΔHc, KEKE truncation had an f/f0 ratio of 1.24 (values near
1.2 correspond to globular shapes) and exists as a monomer
(estimated 30.1 kDa MW from AUC), whereas Uch37ΔKEKE
and the WT Uch37 exist as a mixture of different oligomers in
solution (Figs. 1E and S4). The observation that Uch37ΔKEKE
eluted as a single peak at a position close to that of the
monomer of Uch37 in SEC but behaved as a mixture of oligo-
mers in AUC was intriguing. The deletion of the KEKE motif
may have altered the surface properties of the protein, and
therefore, Uch37ΔKEKE could have oligomerized. Currently, we
do not have a good explanation for this perplexing behavior of
Uch37ΔKEKE. In the crystal structure of Uch37 (PDB ID 3IHR),
theUch37moleculesare packedasa tetramereven though the
KEKE motif is not visible. Therefore, it is likely that the KEKE
motif may not play an essential role in the oligomerization of
Uch37.
Taken together, the crystal packing analysis of Uch37
(PDB ID 3IHR and 3A7S) and the SEC and AUC analyses of
different C-terminal truncations of Uch37 suggest that the
C-terminal extension region, particularly residues 291–303,
play an important role in the oligomerization of the protein in
solution. The coiled-coil interactions of Hc form the basis for
the packing of Uch37 as a tetramer (Fig. S2C). The binding
of Rpn13 to the KEKE motif of Uch37 likely perturbs the
hydrophobic interactions of tetrameric Hc, resulting in dis-
assembly of the oligomer into a monomer via the formation
of a stable Rpn13-Uch37 complex that provides a means to
keep Uch37 in the monomeric state.
Reconstruction of the Uch37-Rpn13C complex
structure by SAXS
To visualize the interaction between Uch37 and Rpn13C, we
employed ab initio and rigid body modeling methods to
construct the Uch37-Rpn13C complex from the SAXS data
(Fig. 5). Ten individual GASBOR calculations without sym-
metry restraint (P1) (Svergun et al., 2001) were performed to
construct a model for the Uch37-Rpn13C complex. The
resultant model of the Uch37-Rpn13C complex had an
acceptable chi value of 1.44 ± 0.21 (Fig. 5A). The consensus
shape of the Uch37-Rpn13C complex mainly contains two
parts—Uch37 (left part) and Rpn13C (right part) (Fig. 5A). In
rigid body modeling, a Uch37 monomer model (PDB ID
3IHR) and the NMR structure of Rpn13C were modeled
together using MASSHA (Konarev et al., 2001) (Fig. 5B).
Considering the ﬂexibility of the KEKE motifs, the ﬁnal chi
value, 1.50, is considered reasonable. Thus, we obtained a
model that is consistent with the biochemical knowledge that
the KEKE motifs of Uch37 and of Rpn13C associate to form
a heterodimer (Fig. 5B and 5C). Furthermore, the atomic
model of the Uch37-Rpn13C complex generated by MAS-
SHA could ﬁt the ab initio low-resolution shape well (Fig. 5C).
In this SAXS-based Uch37-Rpn13C complex model, the
Uch37-binding surface of Rpn13C reported by Chen et al.
was facing toward the Uch37 molecule (Fig. 5D).
Although the overall SAXS-based Uch37-Rpn13C complex
model is in agreement with the model reported by Chen
et al., the distance between the Uch37-binding surface of
Rpn13 and the Uch37 molecule is slightly larger. One pos-
sible reason for this difference might lie in the ﬂexibility of the
SAXS model.
Auto-inhibition of Uch37 and its activation by Rpn13C
To determine why Uch37 exhibited low activity against the
Ub-AMC substrate, which could be hydrolyzed by Uch37
homologs (Fig. 4C), we aligned the structure of the catalytic
domain of Uch37 with those of UCH-L1, UCH-L3, and
YUH1. This analysis revealed that the Uch37 catalytic
domain was highly conserved and contained all of the
components necessary for the catalysis. Because the cat-
alytic domain did not provide sufﬁcient clues about its
mechanism of auto-inhibition, we examined the C-terminal
extension region of Uch37 for its potential role in auto-
inhibition. In solution, Uch37 existed mainly as oligomers
that were primarily mediated by the C-terminal extension
region. In the presence of Rpn13C, Uch37 formed a 1:1
complex with Rpn13C. Such a conﬁguration of Uch37 in
the presence of Rpn13C readily cleaved the substrate Ub-
AMC (Fig. 4C). Thus, the Uch37 oligomerization mediated
by the C-terminal extension region maintained the auto-
inhibition of the enzyme.
To delineate the structural basis of the auto-inhibition of
Uch37 and its activation by Rpn13C, we used a Uch37 dimer
model derived from its crystal structure and compared it with
the structure of the binary complex of ubiquitin-bound Uch37
(PDB ID 4IG7) and its homolog UCH-L3 (PDB ID 1XD3).
These comparisons revealed that the position of Ub is occu-
pied by another molecule in the dimeric Uch37 models,
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preventing access to the active site (Fig. 5E). Thus, in its auto-
inhibited form, a second molecule of Uch37 sterically
obstructs the entry of a substrate, such as Ub-AMC, into the
active site. Rpn13C released Uch37 from the inactive oligo-
meric state by forming a 1:1 complex with Uch37. Rpn13
eliminated the steric hindrance and provided access to the
active site of Uch37, resulting in the activation of Uch37
(Fig. 5D).
The structure of the full-length Rpn13 (PDB ID 2KR0)
contains a Pru domain sitting next to Rpn13C (Chen et al.,
2010). Structural superimposition of the full-length Rpn13
over the heterotrimeric Uch37-Rpn13C-UB model revealed
that the Pru domain of Rpn13 might sit at a position
approximately adjacent to that of Ub. Such an arrangement
of the proteins implied a potential role of the Pru domain in
anchoring the ubiquitins that precede the distal Ub during the
catalysis by Uch37.
Deletion of the C-terminal region-activated Uch37
To further demonstrate that Rpn13C activated Uch37
through de-oligomerization, we performed Ub-AMC activity
assays for Uch37 and its C-terminal region deletion trunca-
tions in the presence or absence of Rpn13. Initial optimiza-
tion studies on the assay conditions revealed that Uch37
alone had some limited activity (Fig. 4D). However, this
activity was very low when compared with the activity of the
Uch37 catalytic domain alone (14.31 ± 1.65 versus 79.55 ±
16.59, considering the activity of UCH-L3 to be 100%)
(Fig. 4D). Concentration-dependent activity assays revealed
that as the concentration of Uch37 alone increased, the
residual activity of Uch37 also increased, with relative
activities of 14.31 ± 1.65, 110.31 ± 1.37, and 264.09 ± 11.62
in 80 pmol/L, 5 nmol/L, and 50 nmol/L, respectively. How-
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Figure 5. Rpn13-activated Uch37 by reversing the oligomerization, as revealed by an SAXS model. (A) Model generated by
GASBOR for the Uch37-Rpn13C complex in solution. The graph illustrates that the model ﬁt the experimental data well. (B) Model of
the Uch37-Rpn13C complex generated by MASSHA. The graph illustrates that the model ﬁt the experimental data well. (C) A low-
resolution envelope of the Uch37-Rpn13C complex with the model ﬁt to the envelope. (D) Dimer of Uch37 displaying one chain in a
surface representation, with the second chain is shown as a cartoon (blue). Complex of UCH-L3 (light green) with Ub (red)
superimposed over the dimer of Uch37 to depict the steric hindrance preventing access to the Uch37 active site. (E) The Rpn13-
Uch37-Ub hetero-trimeric model generated by aligning UCH-L3-Ub (PDB ID 1XD3) and Rpn13 (PDB ID 2KR0) to the Uch37-Rpn13C
complex structure obtained by MASSHA. The steric block is removed when Uch37 associates with Rpn13C (shown as a green
cartoon). The ubiquitin-binding domain (UBD) of Rpn13 (violet magenta) sits next to its Uch37-binding domain (grey) at a position
approximately adjacent to that of Ub such that the UBD could anchor the ubiquitins that precede the terminal ubiquitin during the
catalysis. The Uch37-binding surface of Rpn13C (yellow) is facing the Uch37 molecule.
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dramatic increase in the enzyme activity of Uch37 (143.82 ±
2.63 in 80 pmol/L; 374.06 ± 13.85 in 5 nmol/L; the relative
activity in 50 nmol/L was too high to be measured) (Fig. 4E).
This increase in activity was a function of the enzyme con-
centration. As expected, all three C-terminal truncations of
Uch37 (all without the KEKE motif) could not be activated
any further by Rpn13C (Fig. 4D). This result is consistent
with the inference derived from the biophysical character-
ization of the Uch37-Rpn13C complex that Rpn13 acti-
vates Uch37 through its interaction with the C-terminal
domain of Uch37, particularly the KEKE motif. Furthermore,
Uch37ΔHb,Hc,KEKE and Uch37ΔHc,KEKE displayed greater de-
ubiquitinating activities than did Uch37ΔKEKE (76.41 ± 0.56
and 35.91 ± 3.09 versus 13.32 ± 2.69), which displayed an
activity that was similar to that of the auto-inhibited WT
Uch37 (14.31 ± 1.65). Uch37ΔHb,Hc,KEKE exhibited compa-
rable activity to that of the UCH domains, such as UCH-L3
and was roughly twice as high as that of Uch37ΔHc,KEKE.
This ﬁnding indicates that both Hb and Hc play critical roles
in the auto-inhibition of Uch37. However, it can’t be excluded
that Hb helix itself probably inhibit the activity in other
unexpected way. Taken together, these activity assay results
lend direct support to the conclusion that the auto-inhibition
of Uch37 is a result of its oligomerization, which is shed on
the presence of Rpn13.
Despite the multiple lines of evidence presented here, the
fact that the activity of Uch37 in the presence of Rpn13C is
considerably higher than that of the Uch37 catalytic domain
alone (143.82 ± 2.63 versus 79.55 ± 16.59) suggests that the
hypothesis—Rpn13 releases the oligomerization of Uch37,
resulting in its activation—can partly explain the mechanism
of Uch37 activation. There are likely other factors that con-
tribute to the activation of Uch37 by Rpn13. For example,
Rpn13C could possibly stabilize the Uch37 active-site cross-
over loop, enhancing its activation. In addition, the full-length
Rpn13 or Rpn13 anchored on 19S could bind, stabilize, and
optimally orient poly-ubiquitin chains for Uch37. However,
the basis for any enhancement in the activity of Uch37 lies in
the reversal of its oligomerization, a process that is mediated
by Rpn13.
CONCLUSIONS
Rpn13, which functions as a ubiquitin receptor, and the de-
ubiquitinating enzyme Uch37 are an integral part of the 26S
proteasome. Uch37 by itself has very low de-ubiquitinating
activity. Our analyses of the solution status of Uch37
explained the possible reasons behind this auto-inhibition of
Uch37. Uch37 could form oligomers in solution. Such an
oligomerization of Uch37 was mainly mediated by the coiled-
coil motif of Hc. When in an oligomeric state, the C-terminal
extension region from the other monomer covered and ste-
rically obstructed the placement of ubiquitin into the active
site of another molecule of Uch37. Using a combination of
mutagenesis, biochemical, and small-angle X-ray scattering
(SAXS) techniques, we demonstrated that Rpn13 activated
the auto-inhibited Uch37 by de-oligomerizing it and
sequestering it to form a 1:1 stoichiometric complex. The
ﬁndings help to understand the mechanism of Uch37 auto-




The full-length Uch37 gene was ampliﬁed from a plasmid containing
human Uch37 (a gift from Professor Robert E. Cohen) (Yao et al.,
2006). The resultant gene fragment was ligated into pMCSG7
encoding His-TEV-Uch37 as previously reported (Niu et al., 2013).
Truncations and mutations were designed based on this plasmid
pMCSG7-Uch37 using a Quik ChangeTM site-directed mutagenesis
kit following the manufacturer’s instructions (Stratagene, La Jolla,
CA, USA). The gene encoding full-length Rpn13 was synthesized by
Sangon Biotech (Shanghai) Co., Ltd and was cloned into pET-28b
using BamH I and XhoI. Truncations of Rpn13 were cloned into
pMCSG7 using the method described above. All the plasmids were
sequenced to verify the sequence.
Protein expression and puriﬁcation
The plasmids harboring the target genes were transformed into
E. coli BL21(DE3). The cells were grown in Luria-Bertani (LB)
medium containing ampicillin (100 μg/mL) at 37°C until the OD600
reached 0.8. The culture was then induced with 0.2 mmol/L iso-
propyl-β-D-thiogalactoside (IPTG) for 20 h at 16°C. Cells were har-
vested by centrifugation, lysed by sonication, and clariﬁed by
centrifugation; the supernatant was then applied to a nickel-nitrilo-
triacetic acid (Ni-NTA) resin gravity column (Qiagen, Valencia, CA,
USA) that had been previously equilibrated with PBS (137 mmol/L
NaCl, 2.7 mmol/L KCl, 50 mmol/L Na2HPO4, and 10 mmol/L
KH2PO4 at pH 7.4). The column was ﬁrst washed with 100 mL of
PBS, then washed with 100 mL of PBS containing 20 mmol/L
imidazole, and ﬁnally eluted with PBS containing 300 mmol/L imid-
azole. After buffer exchange, the His-tag was cleaved by a tobacco
etch virus (TEV) treatment. Uncut protein was separated by a sec-
ond Ni-afﬁnity chromatography. Fractions containing the protein
were pooled, concentrated, and loaded on a Superdex G200 size
exclusion chromatography column (Amersham) equilibrated with 20
mmol/L Tris-HCl at pH 8.0, 200 mmol/L NaCl, and 2 mmol/L DTT.
Pure proteins, including Uch37 and Rpn13C, were pooled and
stored at −80°C. Uch37 and Rpn13C were mixed at a ratio of 1:2.
The mixture was loaded onto a Superdex G200 column again to
separate the Uch37-Rpn13C complex from excess Rpn13. The
resulting Uch37-Rpn13C complex was stored at −80°C until further
use.
Size exclusion chromatography (SEC)
Protein samples (approximately 10 mg/mL) were loaded onto a
Superdex G200 column (Amersham) equilibrated with 20 mmol/L
Tris-HCl at pH 8.0, 200 mmol/L NaCl, and 2 mmol/L DTT. The elution
volumes (Ve) were recorded. In the Superdex G200 (120 mL)
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column (void volume V0 = 45.2 mL), ovalbumin (44 kDa) and γ-
globulin (158 kDa) eluted at 82.87 and 66.69 mL, respectively. The
standard curve was obtained by the linear correlation between
log10MW and Ve/V0. The MWs for the proteins and their complexes
were calculated from Ve based on the standard curve.
Analytical ultracentrifugation (AUC) analysis
Analytical sedimentation velocity experiments were conducting
using a ProteomeLab™ XL-I system (Beckman Coulter) according
to our previous report (Ouyang et al., 2012). Brieﬂy, an An-60Ti rotor
was used to centrifuge protein samples suspended in 20 mmol/L
Tris-HCl at pH 8.0, 200 mmol/L NaCl, and 2 mmol/L DTT at 60,000
rpm with an A280nm of approximately 0.8. The absorbance was read
at 280 nm. A set of 93 scans were collected at 1 min intervals. Sedﬁt
software was used for size distribution analysis with a continuous c
(s) distribution model with the default parameters (Schuck, 2000).
After interpretation and reﬁnement of the results, the distribution was
displayed and exported with a conﬁdence level (F-ratio) of 0.9. The
statistics for the AUC runs are listed in Table S2. The MWs of the
globular proteins were obtained by converting the S values with the
f/f0 ratio in Sedﬁt. The percentage distribution of each peak was
obtained by S peak integration in Sedﬁt.
NMR studies on Rpn13C
The plasmid pMCSG7-Rpn13C was transformed into E. coli BL21
(DE3). Cells were grown in M9 medium containing glucose (0.2% M/
V), MgSO4 (1 mmol/L) and ampicillin (100 μg/mL).
15N ammonium
chloride and/or 13C glucose was used for isotope labeling. Labeled
Rpn13C was puriﬁed using the same procedure as for the native
one. The NMR samples of Rpn13C contained approximately 0.5–1.0
mmol/L 15N- and 13C- uniformly labeled protein in 50 mmol/L
phosphate sodium buffer at pH 6.0, 50 mmol/L NaCl, 0.02% (w/v)
sodium 2,2-dimethylsilapentane-5-sulfonate (DSS), and 10% (v/v)
2H2O. All NMR experiments were performed at 298 K on a Bruker
600 MHz NMR spectrometer equipped with a z-gradient triple-res-
onance cryoprobe. Experiments using 2D 1H-15N and 1H-13C HSQC,
3D HNCA, CBCA(CO)NH, HNCACB, HNCO, HN(CA)CO, HBHA
(CO)NH, HBHANH, HCCH-TOCSY, and CCH-TOCSY were per-
formed for the backbone and side chain assignments of Rpn13C.
Additionally, 3D 1H-15N and 1H-13C NOESY-HSQC spectra with
mixing times of 120 ms were collected to generate distance
restraints. All data were processed with Felix (Accelyris Inc.) and
analyzed with NMRViewJ (Johnson and Blevins, 1994). The proton
chemical shifts were referenced to the internal DSS, and the 15N and
13C chemical shifts were referenced indirectly (Markley et al., 1998).
The structures of Rpn13C were initially calculated with the program
CYANA (Güntert et al., 1997) and then reﬁned using CNS (Brunger
et al., 1998), whereas the manual assignments and semi-automated
NOE assignments were performed using SANE (Duggan et al.,
2001). Backbone dihedral angle restraints obtained using TALOS+
(Shen et al., 2009), as well as hydrogen-bond restraints based on
the regular secondary structure patterns, were also incorporated into
the structural reﬁnement. From 100 initial structures, the 50 lowest-
energy conformers of Rpn13C were selected for water-reﬁnement
using CNS and RECOORD Script (Nederveen et al., 2005), and the
20 lowest-energy conformers were selected to represent the ﬁnal
ensemble of structures for Rpn13C. The quality of the structures
were analyzed using MOLMOL (Koradi et al., 1996) and PRO-
CHECK-NMR (Laskowski et al., 1996).
SAXS data collection and analysis
SAXS images were collected at the SIBYLS beamline (Advanced
Light Source, Lorenz Berkeley National Lab, USA). Each sample
was measured with three exposures, 0.5, 1, and 6 s, at 10°C at three
concentrations. Data for Uch37 were collected at 1.25, 2.5, and 5
mg/mL in a buffer composed of 20 mmol/L Tris-HCl at pH 8.0, 200
mmol/L NaCl, and 2 mmol/L DTT, whereas data for Uch37-Rpn13C
were collected at 1.5, 3, and 6 mg/mL. The scattering intensity I
(Q) was measured for Q values (Q = 4πsinθ/λ, where 2θ is the
scattering angle) ranging from 0.01 to 0.3 Å−1. The resulting scat-
tering curves for each sample were radially averaged, and the buffer
was subtracted. The data were integrated, scaled, and buffer sub-
tracted to obtain the standard scattering curves. Multiple curves with
different concentrations and different exposure times were scaled
and averaged to generate the average scattering curve.
The initial Rg values from theGuinier plot analysis were analyzedby
PRIMUS (Konarev et al., 2003). The P(r) distribution function was cal-
culated with the program GNOM (Svergun, 1992). The MW was esti-
mated directly using the P(r) distribution function from the web server
(http://www.if.sc.usp.br/∼saxs/saxsmow.html) (Fischer et al., 2010).
Low-resolution shape reconstructions were modeled by GAS-
BOR (Svergun et al., 2001) from the calculated P(r) distribution
curve. Uch37 and Rpn13C were modeled together based on the
scattering curve using MASSHA (Konarev et al., 2001). Based on
the KEKE interaction between Uch37 and Rpn13C, the position of
Uch37 monomer was ﬁxed, whereas Rpn13C was able to move
freely around Uch37 with the constraint that the distance of the
KEKE motifs was no larger than 7 Å. The high-resolution models
were superimposed onto the low-resolution shape model by SUP-
COMB (Kozin and Svergun, 2001).
Time-resolved small angle X-ray scattering (TR-SAXS)
The steady-state small-angle X-ray scattering (SAXS) experiments
were performed at beamline 12ID-B of the Advanced Photon Source
(APS) at Argonne National Laboratory (Chicago site). The wave-
length, λ, of the X-ray radiation was set to 1.033 Å. The scattered X-
ray intensities were measured using a Pilatus 2M detector (DEC-
TRIS Ltd). The sample-to-detector distance was set such that the
detecting range of the momentum transfer, q [= 4π sinθ/λ, where 2θ
is the scattering angle], of the SAXS experiments was 0.008–0.92
Å−1. To reduce the radiation damage, a ﬂow cell made of a cylindrical
quartz capillary with a diameter of 1.5 mm and a wall of 10 μm was
used, and the exposure time was set to 1–2 s. To obtain good signal-
to-noise ratios, 20 images were taken for each sample and buffer.
The 2-D scattering images were converted to 1-D SAXS curves
through azimuthal averaging after solid-angle correction and then
normalization with the intensity of the transmitted X-ray beam using
the software package developed at beamline 12ID-B. The time-
resolved solution SAXS experiments were performed using a Bio-
Logic SFM-400 stopped-ﬂow mixer coupled to a Pilatus 100K
detector (DECTRIS Ltd) at BioCAT beamline 18ID at APS. The
Uch37 and Rpn13C were mixed at a 1:1 monomer molar ratio with
Mechanism of the Rpn13-induced activation RESEARCH ARTICLE









an overall protein concentration of 3.7 mg/mL. The reaction was
measured in the time range from 8 ms to 600 s. Two parameters, I0
and Rg, were calculated for the system from the Guinier equation [I(q) =
I0*exp(−Rg2*q2/3)] and plotted against the time elapsed after mixing
the two proteins. For a single-component system, I0 is the forward
scattering, a direct indicator of the molecular weight, whereas Rg can
provide information about the overall size of a molecule. For a
system with multiple (N) molecular components, the apparent I0 and
Rg can be written as follows: I0 = ∑
N







, where I0j [=kCjMWj], and Rgj are the parameters for
the jth component, Cj is its concentration in terms of the mass, and
k is a constant.
Uch37 activity assay
Activity measurements were conducted with 80 pmol/L UCH enzyme
and 0.5 μmol/L Ub-AMC (Sigma) as the substrate in the assay buffer
(50 mmol/LTris-HCl at pH 8.0, 0.5 mmol/L EDTA, 1 mmol/L DTT, and
0.1% BSA) at 25°C. For comparison, the activities for UCH-L3 and
Uch37 with or without Rpn13 were measured simultaneously. To
fully release the activity, Rpn13 was added to Uch37 in an excess
molar amount. The ﬂuorescence signals of AMC (excitation, 380 nm;
emission, 460 nm) were monitored using a VarioskanFlash (Thermo
Scientiﬁc) within 30 min. The velocities were determined by ﬁtting
the initial linear data points to a least-squares regression line with R2
scores greater than 0.95. For each sample, the activity assay was
repeated at least three times for statistical analysis.
Fluorescence resonance energy transfer (FRET)
Full-length Uch37 containing only one cysteine (C27) was obtained
by four rounds of QuikChange site-directed mutagenesis. C9, C88,
C100, and C191 were progressively mutated into alanine. The
Uch37 containing only one cysteine (C27) was expressed and
puriﬁed using the procedure mentioned previously. Puriﬁed Uch37
(C27 only) was incubated with a ﬁve-fold molar excess of dye (Alexa
Fluor 555 and Alexa Fluor 647, Invitrogen) for 5 h at 16°C. The
reaction was quenched with a 10-fold excess of DTTover the dye for
1 h at 16°C, and the free dye was separated by gel ﬁltration. FRET
was measured on a VarioskanFlash (Thermo Fisher Scientiﬁc) using
100 μL of labeled Uch37 (250 nmol/L). An excess molar amount of
Rpn13C was added, the mixture was incubated for 30 min, and the
FRET signals were measured.
Surface plasmon resonance (SPR)
SPR experiments were performed in duplicate using a Biacore3000
instrument (Biacore, Inc.) at 25°C in PBS running buffer. Rpn13Cwas
immobilized on CM5 chips following the standard amine coupling
procedure recommended by the manufacturer. For kinetic measure-
ments, sensorgrams were recorded by passing 60 μL of various
concentrations of Uch37 over the immobilized Rpn13C surface at a
ﬂow rate of 30 μL/min with a 2 min association phase followed by a
10-min dissociation phase. The surface was regenerated between
each experimentwith two consecutive injections (0.5min) of 15mmol/L
NaOHat 30 μL/min followed by a 1min equilibration phase in the PBS
buffer before the subsequent experiment. Identical injections over
blank surfaces were subtracted from the data for kinetic analysis. The
binding kinetics were analyzed by BIAevaluation software (Biacore)
using a 1:1 Langmuir binding model. All injections were performed in
duplicate and yielded highly similar results.
ACCESSION CODE
The atomic coordinate and structure factor of Rpn13C were
deposited in the Protein Data Bank (www.pdb.org) and the PDB
code is 2MKZ and the BMRB accession ID is 19801.
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